Robert Batey
Concepts (455)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Riboswitch | 36 | 2024 | 68 | 14.480 |
Why?
| Nucleic Acid Conformation | 62 | 2024 | 705 | 6.530 |
Why?
| RNA, Bacterial | 29 | 2023 | 182 | 6.140 |
Why?
| RNA | 34 | 2025 | 877 | 5.810 |
Why?
| Aptamers, Nucleotide | 24 | 2024 | 78 | 4.100 |
Why?
| Ligands | 33 | 2024 | 616 | 3.430 |
Why?
| Vitamin B 12 | 7 | 2023 | 120 | 3.120 |
Why?
| RNA Folding | 8 | 2023 | 36 | 2.980 |
Why?
| Models, Molecular | 38 | 2025 | 1480 | 2.980 |
Why?
| Bacillus subtilis | 12 | 2020 | 65 | 2.940 |
Why?
| S-Adenosylmethionine | 12 | 2017 | 58 | 2.760 |
Why?
| Base Sequence | 40 | 2023 | 2157 | 2.650 |
Why?
| Purines | 11 | 2019 | 170 | 2.650 |
Why?
| RNA, Messenger | 18 | 2024 | 2702 | 2.580 |
Why?
| Crystallography, X-Ray | 27 | 2022 | 437 | 2.450 |
Why?
| Gene Expression Regulation, Bacterial | 11 | 2024 | 321 | 2.260 |
Why?
| 5' Untranslated Regions | 10 | 2014 | 54 | 2.240 |
Why?
| Binding Sites | 30 | 2025 | 1239 | 1.890 |
Why?
| Transcription, Genetic | 11 | 2020 | 1409 | 1.740 |
Why?
| Gene Expression Regulation | 12 | 2020 | 2523 | 1.490 |
Why?
| Protein Binding | 18 | 2025 | 2087 | 1.400 |
Why?
| Bacterial Proteins | 9 | 2020 | 829 | 1.390 |
Why?
| RNA, Catalytic | 9 | 2024 | 185 | 1.380 |
Why?
| Adenine | 7 | 2020 | 247 | 1.280 |
Why?
| Molecular Sequence Data | 25 | 2015 | 2846 | 1.240 |
Why?
| Regulatory Sequences, Ribonucleic Acid | 6 | 2007 | 19 | 1.190 |
Why?
| Biosensing Techniques | 2 | 2020 | 115 | 1.120 |
Why?
| Flavin Mononucleotide | 2 | 2018 | 7 | 1.000 |
Why?
| Deoxyguanosine | 2 | 2019 | 27 | 0.980 |
Why?
| Heterogeneous-Nuclear Ribonucleoprotein U | 2 | 2024 | 7 | 0.960 |
Why?
| Bacteria | 5 | 2024 | 812 | 0.950 |
Why?
| Tetrahydrofolates | 3 | 2015 | 18 | 0.940 |
Why?
| Escherichia coli | 10 | 2020 | 784 | 0.940 |
Why?
| Genetic Engineering | 3 | 2014 | 90 | 0.920 |
Why?
| Biochemical Phenomena | 1 | 2023 | 10 | 0.850 |
Why?
| Introns | 4 | 2014 | 242 | 0.850 |
Why?
| Guanine | 6 | 2011 | 79 | 0.840 |
Why?
| RNA-Binding Proteins | 7 | 2025 | 382 | 0.830 |
Why?
| HMGB Proteins | 1 | 2023 | 16 | 0.830 |
Why?
| Signal Recognition Particle | 6 | 2007 | 9 | 0.820 |
Why?
| CRISPR-Cas Systems | 2 | 2020 | 109 | 0.790 |
Why?
| Base Pairing | 12 | 2020 | 62 | 0.770 |
Why?
| Models, Genetic | 3 | 2020 | 588 | 0.720 |
Why?
| Escherichia coli K12 | 1 | 2020 | 8 | 0.720 |
Why?
| CRISPR-Associated Proteins | 1 | 2020 | 1 | 0.720 |
Why?
| Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 16 | 0.710 |
Why?
| Protein Biosynthesis | 3 | 2016 | 409 | 0.710 |
Why?
| Enzyme Assays | 1 | 2020 | 25 | 0.700 |
Why?
| Ribosomal Proteins | 6 | 2006 | 76 | 0.700 |
Why?
| Magnesium | 8 | 2015 | 151 | 0.690 |
Why?
| Chromatography, Affinity | 3 | 2009 | 83 | 0.680 |
Why?
| Lysine | 3 | 2012 | 266 | 0.680 |
Why?
| Endodeoxyribonucleases | 1 | 2020 | 65 | 0.680 |
Why?
| SOXB1 Transcription Factors | 1 | 2020 | 55 | 0.660 |
Why?
| Thermodynamics | 12 | 2014 | 403 | 0.660 |
Why?
| Gene Editing | 1 | 2020 | 66 | 0.650 |
Why?
| RNA, Long Noncoding | 4 | 2022 | 176 | 0.600 |
Why?
| Quinoxalines | 1 | 2018 | 64 | 0.590 |
Why?
| Crystallization | 7 | 2019 | 136 | 0.570 |
Why?
| Archaeal Proteins | 2 | 2009 | 48 | 0.570 |
Why?
| Dihydroxyphenylalanine | 1 | 2017 | 9 | 0.550 |
Why?
| 5-Hydroxytryptophan | 1 | 2017 | 20 | 0.550 |
Why?
| Cobamides | 1 | 2017 | 21 | 0.550 |
Why?
| Ribosomes | 3 | 2006 | 163 | 0.530 |
Why?
| Receptors, Glucocorticoid | 3 | 2023 | 145 | 0.530 |
Why?
| Synthetic Biology | 2 | 2014 | 14 | 0.530 |
Why?
| Cyanobacteria | 1 | 2017 | 63 | 0.520 |
Why?
| Coenzymes | 1 | 2016 | 17 | 0.520 |
Why?
| Mutation | 9 | 2017 | 3679 | 0.520 |
Why?
| Kinetics | 9 | 2017 | 1622 | 0.520 |
Why?
| Sequence Analysis, RNA | 1 | 2018 | 422 | 0.520 |
Why?
| Small Molecule Libraries | 1 | 2017 | 85 | 0.520 |
Why?
| X-Ray Diffraction | 1 | 2016 | 93 | 0.500 |
Why?
| Calorimetry | 3 | 2012 | 66 | 0.500 |
Why?
| Conserved Sequence | 8 | 2017 | 228 | 0.500 |
Why?
| DNA | 7 | 2025 | 1407 | 0.480 |
Why?
| Chemical Fractionation | 1 | 2014 | 28 | 0.450 |
Why?
| Folic Acid Antagonists | 1 | 2014 | 9 | 0.450 |
Why?
| Thermotoga maritima | 3 | 2009 | 11 | 0.440 |
Why?
| S-Adenosylhomocysteine | 2 | 2010 | 24 | 0.440 |
Why?
| Ribonucleotides | 5 | 2017 | 26 | 0.420 |
Why?
| Purine Nucleotides | 1 | 2013 | 12 | 0.420 |
Why?
| Static Electricity | 5 | 2020 | 116 | 0.410 |
Why?
| Ribonucleoproteins | 3 | 2020 | 90 | 0.390 |
Why?
| Streptococcus mutans | 1 | 2011 | 8 | 0.380 |
Why?
| RNA, Ribosomal | 3 | 2003 | 162 | 0.380 |
Why?
| Substrate Specificity | 5 | 2018 | 372 | 0.380 |
Why?
| Intrinsically Disordered Proteins | 2 | 2024 | 30 | 0.360 |
Why?
| RNA, Ribosomal, 16S | 4 | 1999 | 521 | 0.360 |
Why?
| Gene Regulatory Networks | 1 | 2013 | 279 | 0.360 |
Why?
| RNA, Archaeal | 2 | 2009 | 16 | 0.350 |
Why?
| Mouse Embryonic Stem Cells | 2 | 2020 | 24 | 0.340 |
Why?
| DNA-Binding Proteins | 4 | 2023 | 1424 | 0.340 |
Why?
| Pyrococcus horikoshii | 1 | 2009 | 4 | 0.320 |
Why?
| Ribonucleoproteins, Small Nuclear | 1 | 2009 | 23 | 0.320 |
Why?
| Molecular Structure | 4 | 2018 | 469 | 0.320 |
Why?
| Transcription Factors | 5 | 2023 | 1636 | 0.310 |
Why?
| Geobacillus stearothermophilus | 3 | 1998 | 12 | 0.310 |
Why?
| Ethanol | 5 | 2000 | 584 | 0.310 |
Why?
| Protein Structure, Secondary | 5 | 2011 | 335 | 0.310 |
Why?
| Models, Chemical | 3 | 2008 | 263 | 0.300 |
Why?
| Anti-Bacterial Agents | 2 | 2018 | 1702 | 0.300 |
Why?
| Genes, Reporter | 2 | 2020 | 269 | 0.300 |
Why?
| Proteobacteria | 1 | 2008 | 16 | 0.300 |
Why?
| Gene Expression | 5 | 2014 | 1477 | 0.300 |
Why?
| Hydrogen Bonding | 5 | 2012 | 149 | 0.290 |
Why?
| Electrophoretic Mobility Shift Assay | 2 | 2024 | 82 | 0.290 |
Why?
| Fluorescent Dyes | 2 | 2020 | 319 | 0.290 |
Why?
| Tumor Necrosis Factor-alpha | 5 | 2000 | 1204 | 0.280 |
Why?
| Protein Domains | 4 | 2025 | 243 | 0.280 |
Why?
| Genes, Switch | 1 | 2006 | 6 | 0.280 |
Why?
| Ribonucleoproteins, Small Nucleolar | 1 | 2006 | 3 | 0.270 |
Why?
| RNA, Small Nucleolar | 1 | 2006 | 8 | 0.270 |
Why?
| Thermoanaerobacter | 1 | 2006 | 1 | 0.270 |
Why?
| Pyrimidines | 2 | 2006 | 444 | 0.260 |
Why?
| SELEX Aptamer Technique | 1 | 2005 | 14 | 0.250 |
Why?
| Methyltransferases | 1 | 2006 | 72 | 0.250 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2006 | 87 | 0.250 |
Why?
| Magnetic Resonance Spectroscopy | 5 | 2004 | 511 | 0.250 |
Why?
| Telomerase | 1 | 2008 | 229 | 0.250 |
Why?
| Protein Structure, Tertiary | 6 | 2009 | 835 | 0.250 |
Why?
| Isotope Labeling | 2 | 1996 | 73 | 0.250 |
Why?
| Cobalt | 3 | 2016 | 52 | 0.250 |
Why?
| Mutagenesis | 2 | 2020 | 179 | 0.240 |
Why?
| Binding, Competitive | 3 | 2020 | 208 | 0.240 |
Why?
| GATA1 Transcription Factor | 1 | 2025 | 16 | 0.240 |
Why?
| Amino Acid Motifs | 2 | 2024 | 210 | 0.240 |
Why?
| Hypoxanthine | 1 | 2004 | 11 | 0.240 |
Why?
| RNA-Binding Motifs | 1 | 2024 | 2 | 0.230 |
Why?
| Animals | 24 | 2020 | 34708 | 0.230 |
Why?
| Fluorescence Polarization | 1 | 2024 | 37 | 0.230 |
Why?
| Dexamethasone | 2 | 2023 | 331 | 0.230 |
Why?
| Structure-Activity Relationship | 3 | 2018 | 540 | 0.220 |
Why?
| Alcohol Dehydrogenase | 2 | 1994 | 16 | 0.220 |
Why?
| Liver | 5 | 1998 | 1835 | 0.220 |
Why?
| X Chromosome Inactivation | 2 | 2020 | 24 | 0.220 |
Why?
| Phylogeny | 4 | 2014 | 844 | 0.210 |
Why?
| Escherichia coli Proteins | 3 | 2007 | 179 | 0.210 |
Why?
| RNA, Viral | 2 | 2020 | 622 | 0.210 |
Why?
| Cations, Monovalent | 1 | 2002 | 6 | 0.210 |
Why?
| RNA, Protozoan | 2 | 2004 | 58 | 0.200 |
Why?
| Cations, Divalent | 1 | 2002 | 54 | 0.200 |
Why?
| Leucovorin | 2 | 2014 | 69 | 0.200 |
Why?
| Iridium | 2 | 2016 | 7 | 0.200 |
Why?
| Sequence Deletion | 2 | 2020 | 180 | 0.200 |
Why?
| Metals | 1 | 2002 | 126 | 0.190 |
Why?
| Estrogen Receptor alpha | 1 | 2022 | 131 | 0.190 |
Why?
| Cations | 3 | 2016 | 80 | 0.180 |
Why?
| Leptotrichia | 1 | 2020 | 1 | 0.180 |
Why?
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 5 | 0.180 |
Why?
| Liver Diseases, Alcoholic | 2 | 2000 | 87 | 0.180 |
Why?
| Molecular Conformation | 3 | 2014 | 141 | 0.180 |
Why?
| Rats, Wistar | 8 | 2000 | 396 | 0.180 |
Why?
| Terminator Regions, Genetic | 2 | 2011 | 12 | 0.180 |
Why?
| Hepatitis, Animal | 1 | 2000 | 2 | 0.180 |
Why?
| Nucleotide Motifs | 1 | 2020 | 33 | 0.180 |
Why?
| Drugs, Chinese Herbal | 1 | 2000 | 13 | 0.170 |
Why?
| Computational Biology | 1 | 2024 | 588 | 0.170 |
Why?
| Recombinant Proteins | 3 | 2017 | 1306 | 0.170 |
Why?
| X Chromosome | 1 | 2020 | 51 | 0.170 |
Why?
| Helicobacter pylori | 4 | 2001 | 37 | 0.170 |
Why?
| Rifampin | 1 | 2020 | 82 | 0.170 |
Why?
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 28 | 0.170 |
Why?
| Theophylline | 1 | 2020 | 66 | 0.170 |
Why?
| Gram-Negative Aerobic Bacteria | 2 | 1996 | 5 | 0.170 |
Why?
| Endogenous Retroviruses | 1 | 2020 | 31 | 0.170 |
Why?
| Liver Cirrhosis, Alcoholic | 2 | 1998 | 17 | 0.160 |
Why?
| Nitrogen Isotopes | 2 | 1996 | 58 | 0.160 |
Why?
| Point Mutation | 2 | 2011 | 226 | 0.160 |
Why?
| Aminoimidazole Carboxamide | 2 | 2017 | 11 | 0.160 |
Why?
| Evolution, Molecular | 3 | 2014 | 465 | 0.160 |
Why?
| Cloning, Molecular | 1 | 2020 | 536 | 0.160 |
Why?
| Carbon Isotopes | 2 | 1996 | 122 | 0.150 |
Why?
| Models, Biological | 4 | 2017 | 1704 | 0.150 |
Why?
| Fluorescence | 2 | 2018 | 159 | 0.150 |
Why?
| Humans | 26 | 2025 | 129079 | 0.150 |
Why?
| Tetrahymena thermophila | 3 | 2004 | 63 | 0.150 |
Why?
| Fructose | 2 | 2015 | 103 | 0.150 |
Why?
| Genes, Bacterial | 3 | 2009 | 159 | 0.150 |
Why?
| 2-Aminopurine | 2 | 2009 | 10 | 0.150 |
Why?
| Polymerase Chain Reaction | 4 | 2009 | 1045 | 0.140 |
Why?
| Drug Design | 1 | 2018 | 156 | 0.140 |
Why?
| Aquatic Organisms | 1 | 2017 | 7 | 0.140 |
Why?
| Transcriptome | 1 | 2023 | 875 | 0.140 |
Why?
| Rats | 10 | 2015 | 5254 | 0.140 |
Why?
| Endotoxemia | 1 | 1998 | 95 | 0.140 |
Why?
| T-Lymphocytes | 6 | 2001 | 1913 | 0.140 |
Why?
| Microscopy, Fluorescence | 1 | 2018 | 404 | 0.130 |
Why?
| Temperature | 3 | 2008 | 635 | 0.130 |
Why?
| Deuterium | 1 | 1996 | 84 | 0.130 |
Why?
| Affinity Labels | 2 | 2007 | 25 | 0.130 |
Why?
| Intubation, Gastrointestinal | 1 | 1996 | 76 | 0.130 |
Why?
| Xanthones | 1 | 2015 | 5 | 0.130 |
Why?
| Salts | 1 | 2016 | 37 | 0.130 |
Why?
| Nucleotides | 1 | 1996 | 117 | 0.130 |
Why?
| Species Specificity | 1 | 2017 | 568 | 0.130 |
Why?
| CD36 Antigens | 1 | 2015 | 35 | 0.130 |
Why?
| MicroRNAs | 1 | 2022 | 669 | 0.130 |
Why?
| Genetic Variation | 1 | 2020 | 935 | 0.120 |
Why?
| Hydrogen-Ion Concentration | 3 | 2009 | 542 | 0.120 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 2000 | 1044 | 0.120 |
Why?
| Viral Proteins | 3 | 2009 | 329 | 0.120 |
Why?
| Gastrostomy | 1 | 1996 | 113 | 0.120 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2014 | 150 | 0.120 |
Why?
| Protein Engineering | 1 | 2016 | 113 | 0.120 |
Why?
| Monocytes | 1 | 1998 | 553 | 0.120 |
Why?
| Protein Conformation | 3 | 2004 | 853 | 0.120 |
Why?
| Hydroxocobalamin | 1 | 2014 | 26 | 0.110 |
Why?
| Interleukin-1 | 2 | 1998 | 972 | 0.110 |
Why?
| Chemical and Drug Induced Liver Injury | 1 | 1995 | 136 | 0.110 |
Why?
| Transcription Termination, Genetic | 1 | 2014 | 15 | 0.110 |
Why?
| Molecular Docking Simulation | 1 | 2014 | 108 | 0.110 |
Why?
| Plasmids | 2 | 2018 | 358 | 0.110 |
Why?
| RNA Stability | 1 | 2014 | 101 | 0.110 |
Why?
| Fatty Liver | 1 | 1995 | 230 | 0.100 |
Why?
| RNA, Transfer | 1 | 2014 | 131 | 0.100 |
Why?
| Hepatitis B | 1 | 1993 | 62 | 0.100 |
Why?
| Concanavalin A | 4 | 2000 | 75 | 0.100 |
Why?
| HIV Long Terminal Repeat | 1 | 1992 | 10 | 0.100 |
Why?
| Cytoplasm | 1 | 1993 | 260 | 0.100 |
Why?
| Methotrexate | 1 | 2014 | 248 | 0.100 |
Why?
| Cytoskeleton | 1 | 1993 | 178 | 0.100 |
Why?
| Dietary Carbohydrates | 1 | 1993 | 151 | 0.100 |
Why?
| Metabolic Syndrome | 1 | 2015 | 339 | 0.100 |
Why?
| Guanosine Triphosphate | 2 | 2004 | 92 | 0.100 |
Why?
| Interleukin-6 | 4 | 2000 | 716 | 0.100 |
Why?
| Fusobacterium nucleatum | 1 | 2011 | 3 | 0.090 |
Why?
| Operator Regions, Genetic | 1 | 1991 | 7 | 0.090 |
Why?
| Potassium Chloride | 1 | 1991 | 34 | 0.090 |
Why?
| Drug Discovery | 1 | 2012 | 130 | 0.090 |
Why?
| Mice | 5 | 2020 | 16583 | 0.090 |
Why?
| Amino Acid Sequence | 2 | 2009 | 2050 | 0.090 |
Why?
| Alcohol Drinking | 2 | 1995 | 742 | 0.090 |
Why?
| Potassium | 2 | 2002 | 140 | 0.090 |
Why?
| Bacteriophage lambda | 1 | 1991 | 85 | 0.090 |
Why?
| Scattering, Small Angle | 1 | 2010 | 20 | 0.090 |
Why?
| Crystallography | 1 | 2010 | 25 | 0.090 |
Why?
| Duodenum | 3 | 1996 | 70 | 0.090 |
Why?
| Folic Acid | 1 | 2011 | 182 | 0.090 |
Why?
| Adenosine | 2 | 2009 | 213 | 0.080 |
Why?
| Replication Protein A | 1 | 2009 | 12 | 0.080 |
Why?
| Clostridium botulinum | 1 | 2009 | 4 | 0.080 |
Why?
| Central Nervous System Depressants | 2 | 2000 | 84 | 0.080 |
Why?
| Gastritis | 2 | 2000 | 98 | 0.080 |
Why?
| Titrimetry | 1 | 2009 | 10 | 0.080 |
Why?
| DNA, Viral | 1 | 1991 | 380 | 0.080 |
Why?
| Nucleic Acid Denaturation | 1 | 2009 | 32 | 0.080 |
Why?
| Schizosaccharomyces pombe Proteins | 1 | 2009 | 47 | 0.080 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 326 | 0.080 |
Why?
| Open Reading Frames | 1 | 2009 | 123 | 0.080 |
Why?
| Glucocorticoids | 2 | 2023 | 571 | 0.080 |
Why?
| 3' Untranslated Regions | 1 | 2009 | 137 | 0.080 |
Why?
| DNA-Directed RNA Polymerases | 1 | 2009 | 57 | 0.080 |
Why?
| DNA, Bacterial | 2 | 2008 | 324 | 0.080 |
Why?
| Protein Interaction Mapping | 1 | 2009 | 107 | 0.080 |
Why?
| Sequence Alignment | 1 | 2009 | 333 | 0.080 |
Why?
| Telomere-Binding Proteins | 1 | 2009 | 102 | 0.080 |
Why?
| ortho-Aminobenzoates | 1 | 2008 | 8 | 0.070 |
Why?
| Exons | 1 | 2009 | 332 | 0.070 |
Why?
| Lipopolysaccharides | 4 | 2000 | 877 | 0.070 |
Why?
| Anhydrides | 1 | 2008 | 18 | 0.070 |
Why?
| Repressor Proteins | 1 | 1991 | 400 | 0.070 |
Why?
| DNA Mutational Analysis | 1 | 2009 | 391 | 0.070 |
Why?
| Nucleic Acids | 1 | 2008 | 60 | 0.070 |
Why?
| Insulin Resistance | 1 | 2015 | 1164 | 0.070 |
Why?
| Telomere | 1 | 2009 | 231 | 0.070 |
Why?
| History, 21st Century | 1 | 2008 | 183 | 0.070 |
Why?
| Base Pair Mismatch | 1 | 2006 | 14 | 0.070 |
Why?
| Hypoglycemic Agents | 1 | 2015 | 1208 | 0.070 |
Why?
| Azoarcus | 1 | 2006 | 1 | 0.070 |
Why?
| History, 20th Century | 1 | 2008 | 295 | 0.070 |
Why?
| Interleukin-2 | 2 | 2001 | 428 | 0.070 |
Why?
| Helicobacter Infections | 3 | 2001 | 28 | 0.070 |
Why?
| Thiamine Pyrophosphate | 1 | 2006 | 2 | 0.060 |
Why?
| Sulfur | 1 | 2006 | 50 | 0.060 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2009 | 367 | 0.060 |
Why?
| Female | 20 | 2020 | 68274 | 0.060 |
Why?
| Methylation | 1 | 2006 | 228 | 0.060 |
Why?
| Alternative Splicing | 1 | 2008 | 216 | 0.060 |
Why?
| Cell Cycle Proteins | 1 | 2009 | 576 | 0.060 |
Why?
| Methionine | 1 | 2006 | 158 | 0.060 |
Why?
| Muscle, Skeletal | 1 | 2015 | 1629 | 0.060 |
Why?
| HEK293 Cells | 2 | 2018 | 674 | 0.060 |
Why?
| Alanine Transaminase | 3 | 2000 | 147 | 0.060 |
Why?
| Operon | 1 | 2004 | 62 | 0.060 |
Why?
| Time Factors | 3 | 2009 | 6579 | 0.060 |
Why?
| Methanococcus | 1 | 2004 | 9 | 0.060 |
Why?
| Microscopy, Electron | 2 | 1995 | 419 | 0.060 |
Why?
| Lymphocyte Activation | 2 | 1998 | 1094 | 0.060 |
Why?
| Membrane Transport Proteins | 1 | 2004 | 148 | 0.050 |
Why?
| Male | 9 | 2020 | 63248 | 0.050 |
Why?
| Cesium | 1 | 2002 | 18 | 0.050 |
Why?
| Energy Transfer | 1 | 2002 | 51 | 0.050 |
Why?
| Fluorescence Resonance Energy Transfer | 2 | 2014 | 175 | 0.050 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 210 | 0.050 |
Why?
| Enterocytes | 1 | 2001 | 15 | 0.050 |
Why?
| Antigens, Bacterial | 2 | 2000 | 120 | 0.050 |
Why?
| Interferon-gamma | 3 | 2001 | 759 | 0.050 |
Why?
| Cell Membrane Permeability | 1 | 2001 | 82 | 0.050 |
Why?
| Transcriptional Activation | 1 | 2023 | 361 | 0.050 |
Why?
| RNA, Untranslated | 1 | 2022 | 114 | 0.050 |
Why?
| RNA Splicing | 1 | 2022 | 254 | 0.040 |
Why?
| Endopeptidases | 1 | 2001 | 82 | 0.040 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 136 | 0.040 |
Why?
| Dosage Compensation, Genetic | 1 | 2020 | 12 | 0.040 |
Why?
| Transformation, Bacterial | 1 | 2000 | 6 | 0.040 |
Why?
| Stomach Neoplasms | 1 | 2001 | 97 | 0.040 |
Why?
| Hepatitis, Alcoholic | 1 | 1999 | 13 | 0.040 |
Why?
| Chromatin | 1 | 2023 | 471 | 0.040 |
Why?
| RNA, Small Nuclear | 1 | 2018 | 35 | 0.040 |
Why?
| Liver Cirrhosis, Experimental | 1 | 1998 | 11 | 0.040 |
Why?
| Color | 1 | 2018 | 73 | 0.040 |
Why?
| Kupffer Cells | 1 | 1998 | 49 | 0.040 |
Why?
| Tetrahymena | 1 | 1998 | 157 | 0.040 |
Why?
| RNA-Binding Protein FUS | 1 | 2017 | 13 | 0.040 |
Why?
| Cell Nucleus | 1 | 2020 | 571 | 0.040 |
Why?
| G-Quadruplexes | 1 | 2017 | 17 | 0.040 |
Why?
| Dinucleoside Phosphates | 1 | 2017 | 27 | 0.030 |
Why?
| Fragile X Mental Retardation Protein | 1 | 2017 | 55 | 0.030 |
Why?
| Cell Line | 2 | 2020 | 2762 | 0.030 |
Why?
| Host-Pathogen Interactions | 1 | 2020 | 348 | 0.030 |
Why?
| Diethyl Pyrocarbonate | 1 | 1996 | 2 | 0.030 |
Why?
| Ethylnitrosourea | 1 | 1996 | 10 | 0.030 |
Why?
| Gastroscopy | 1 | 1996 | 18 | 0.030 |
Why?
| Thionucleotides | 1 | 1996 | 34 | 0.030 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 1998 | 249 | 0.030 |
Why?
| Green Fluorescent Proteins | 1 | 2018 | 392 | 0.030 |
Why?
| HeLa Cells | 1 | 2018 | 602 | 0.030 |
Why?
| Protein Folding | 1 | 1998 | 263 | 0.030 |
Why?
| Oligoribonucleotides | 1 | 1996 | 52 | 0.030 |
Why?
| Glutamine | 1 | 2017 | 94 | 0.030 |
Why?
| Water | 1 | 2000 | 441 | 0.030 |
Why?
| Iodine | 1 | 1996 | 22 | 0.030 |
Why?
| Endoribonucleases | 1 | 2017 | 70 | 0.030 |
Why?
| Hydrazines | 1 | 1996 | 33 | 0.030 |
Why?
| New South Wales | 2 | 1993 | 14 | 0.030 |
Why?
| Cell Membrane | 1 | 2000 | 729 | 0.030 |
Why?
| Rats, Inbred WKY | 1 | 2015 | 34 | 0.030 |
Why?
| Rats, Inbred SHR | 1 | 2015 | 43 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 1996 | 357 | 0.030 |
Why?
| Antibiotic Prophylaxis | 1 | 1996 | 105 | 0.030 |
Why?
| Deoxyribonucleotides | 1 | 1995 | 19 | 0.030 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 1996 | 226 | 0.030 |
Why?
| Fatty Acids, Nonesterified | 1 | 2015 | 158 | 0.030 |
Why?
| Craniocerebral Trauma | 1 | 1996 | 154 | 0.030 |
Why?
| Enteral Nutrition | 1 | 1996 | 186 | 0.030 |
Why?
| Hydrolysis | 1 | 1995 | 191 | 0.030 |
Why?
| Culture Media | 1 | 1995 | 168 | 0.030 |
Why?
| Glucose Tolerance Test | 1 | 2015 | 356 | 0.030 |
Why?
| Tissue Embedding | 1 | 1993 | 3 | 0.030 |
Why?
| Adenocarcinoma | 1 | 2001 | 898 | 0.030 |
Why?
| Hepatitis B Core Antigens | 1 | 1993 | 4 | 0.030 |
Why?
| Hepatitis B Surface Antigens | 1 | 1993 | 19 | 0.030 |
Why?
| Hepatitis B Antibodies | 1 | 1993 | 12 | 0.030 |
Why?
| Killer Cells, Lymphokine-Activated | 1 | 1993 | 12 | 0.030 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 1 | 1993 | 87 | 0.030 |
Why?
| Urban Health | 1 | 1993 | 78 | 0.030 |
Why?
| Nervous System Diseases | 1 | 1996 | 260 | 0.030 |
Why?
| Hepatitis B virus | 1 | 1993 | 34 | 0.030 |
Why?
| Glucose Solution, Hypertonic | 1 | 1993 | 1 | 0.030 |
Why?
| Aged, 80 and over | 4 | 2001 | 7063 | 0.030 |
Why?
| Surgical Wound Infection | 1 | 1996 | 291 | 0.030 |
Why?
| Injections, Intraperitoneal | 1 | 1993 | 106 | 0.030 |
Why?
| Seroepidemiologic Studies | 1 | 1993 | 155 | 0.030 |
Why?
| Triglycerides | 1 | 2015 | 519 | 0.030 |
Why?
| Middle Aged | 8 | 2001 | 31024 | 0.030 |
Why?
| Metabolic Clearance Rate | 1 | 1993 | 107 | 0.030 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1995 | 487 | 0.030 |
Why?
| Methylococcaceae | 1 | 1992 | 2 | 0.030 |
Why?
| Cell Division | 3 | 2001 | 802 | 0.030 |
Why?
| Cytokines | 3 | 1996 | 1997 | 0.020 |
Why?
| Autoradiography | 1 | 1991 | 76 | 0.020 |
Why?
| DNA Fingerprinting | 1 | 1991 | 25 | 0.020 |
Why?
| Viral Regulatory and Accessory Proteins | 1 | 1991 | 27 | 0.020 |
Why?
| Adipose Tissue | 1 | 2015 | 588 | 0.020 |
Why?
| Electrochemistry | 1 | 1991 | 81 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2018 | 3114 | 0.020 |
Why?
| Antigens, CD | 1 | 1993 | 480 | 0.020 |
Why?
| Urease | 2 | 2000 | 9 | 0.020 |
Why?
| Interleukin-4 | 2 | 2001 | 214 | 0.020 |
Why?
| Interleukin-8 | 2 | 2001 | 261 | 0.020 |
Why?
| Immunoglobulin A | 2 | 2001 | 190 | 0.020 |
Why?
| Chloride Channels | 2 | 2001 | 38 | 0.020 |
Why?
| Heroin Dependence | 1 | 1989 | 31 | 0.020 |
Why?
| Case-Control Studies | 1 | 1996 | 3336 | 0.020 |
Why?
| Polyethylene Glycols | 1 | 1993 | 598 | 0.020 |
Why?
| Lymphocyte Count | 2 | 1998 | 149 | 0.020 |
Why?
| Methadone | 1 | 1989 | 93 | 0.020 |
Why?
| Phosphorylation | 1 | 1992 | 1686 | 0.020 |
Why?
| Aged | 5 | 2001 | 22068 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 822 | 0.020 |
Why?
| Prevalence | 1 | 1993 | 2541 | 0.020 |
Why?
| Computer Simulation | 1 | 2011 | 943 | 0.020 |
Why?
| Immunoglobulin G | 2 | 2001 | 837 | 0.020 |
Why?
| Adult | 7 | 2001 | 35423 | 0.020 |
Why?
| Disease Models, Animal | 1 | 1995 | 3999 | 0.020 |
Why?
| Ambulatory Care | 1 | 1989 | 509 | 0.020 |
Why?
| Pregnancy Complications | 1 | 1989 | 487 | 0.010 |
Why?
| Cells, Cultured | 2 | 2001 | 4063 | 0.010 |
Why?
| Immunohistochemistry | 2 | 1998 | 1697 | 0.010 |
Why?
| Blood Glucose | 1 | 1993 | 2088 | 0.010 |
Why?
| Cross-Sectional Studies | 1 | 1993 | 5036 | 0.010 |
Why?
| Xanthine | 1 | 2001 | 7 | 0.010 |
Why?
| Treatment Outcome | 1 | 1996 | 10256 | 0.010 |
Why?
| Thymidine | 1 | 2001 | 58 | 0.010 |
Why?
| Colforsin | 1 | 2001 | 51 | 0.010 |
Why?
| Mannitol | 1 | 2001 | 35 | 0.010 |
Why?
| Receptors, Interleukin-2 | 1 | 2001 | 65 | 0.010 |
Why?
| RNA Probes | 1 | 2001 | 13 | 0.010 |
Why?
| Hepatitis Delta Virus | 1 | 2001 | 7 | 0.010 |
Why?
| RNA, Ribosomal, 23S | 1 | 2001 | 13 | 0.010 |
Why?
| Cyclic AMP | 1 | 2001 | 230 | 0.010 |
Why?
| Dyspepsia | 1 | 2000 | 10 | 0.010 |
Why?
| Blood Cells | 1 | 2000 | 39 | 0.010 |
Why?
| Gastric Mucosa | 1 | 2000 | 50 | 0.010 |
Why?
| Intestine, Small | 1 | 2001 | 140 | 0.010 |
Why?
| Antibodies, Bacterial | 1 | 2001 | 138 | 0.010 |
Why?
| CD4 Antigens | 1 | 2000 | 137 | 0.010 |
Why?
| Mitogens | 1 | 1999 | 58 | 0.010 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 957 | 0.010 |
Why?
| Retrospective Studies | 1 | 1996 | 14562 | 0.010 |
Why?
| Analysis of Variance | 1 | 2001 | 1285 | 0.010 |
Why?
| Endotoxins | 1 | 1999 | 221 | 0.010 |
Why?
| Lymphocyte Subsets | 1 | 1998 | 85 | 0.010 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2001 | 316 | 0.010 |
Why?
| Disaccharidases | 1 | 1996 | 1 | 0.010 |
Why?
| Ion Transport | 1 | 1996 | 57 | 0.010 |
Why?
| Mucins | 1 | 1996 | 71 | 0.010 |
Why?
| Immunoblotting | 1 | 1996 | 302 | 0.010 |
Why?
| Keratins | 1 | 1996 | 176 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 411 | 0.010 |
Why?
| Epithelium | 1 | 1996 | 312 | 0.010 |
Why?
| Cycloheximide | 1 | 1994 | 55 | 0.010 |
Why?
| DNA Probes | 1 | 1994 | 61 | 0.010 |
Why?
| Chronic Disease | 1 | 2000 | 1717 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 2000 | 1361 | 0.010 |
Why?
| Child | 1 | 1993 | 20860 | 0.010 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 149 | 0.010 |
Why?
| CD56 Antigen | 1 | 1993 | 37 | 0.010 |
Why?
| Receptors, IgG | 1 | 1993 | 73 | 0.010 |
Why?
| DNA Primers | 1 | 1994 | 522 | 0.010 |
Why?
| CD3 Complex | 1 | 1993 | 100 | 0.010 |
Why?
| Cell Adhesion Molecules | 1 | 1994 | 177 | 0.010 |
Why?
| Immunoenzyme Techniques | 1 | 1993 | 210 | 0.010 |
Why?
| Cytotoxicity, Immunologic | 1 | 1993 | 216 | 0.010 |
Why?
| Interleukins | 1 | 1994 | 245 | 0.010 |
Why?
| In Vitro Techniques | 1 | 1994 | 1061 | 0.010 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1998 | 833 | 0.010 |
Why?
| Apoptosis | 1 | 1999 | 2485 | 0.010 |
Why?
| Epithelial Cells | 1 | 1996 | 1063 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1989 | 175 | 0.010 |
Why?
| Fibroblasts | 1 | 1994 | 946 | 0.000 |
Why?
| Intestinal Mucosa | 1 | 1993 | 570 | 0.000 |
Why?
| Prospective Studies | 1 | 1989 | 7070 | 0.000 |
Why?
| Pregnancy | 1 | 1989 | 6256 | 0.000 |
Why?
|
|
Batey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|